Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 0.1 | uM | 7 | 5000.00 | 1243.75 | 7715.00 | 7786.75 | 0.9908 | 0.9930 |
| BT-20 | Erlotinib | 1 | uM | 7 | 5000.00 | 1243.75 | 6491.00 | 7786.75 | 0.8336 | 0.8671 |
| BT-20 | Linsitinib | 19.9526 | uM | 7 | 5000.00 | 1243.75 | 5248.00 | 7786.75 | 0.6740 | 0.7230 |
| BT-20 | Erlotinib | 0.031623 | uM | 7 | 5000.00 | 1243.75 | 7419.00 | 7786.75 | 0.9528 | 0.9638 |
| BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 7680.00 | 7786.75 | 0.9863 | 0.9896 | |
| BT-20 | 17-AAG | 3.1623 | uM | 7 | 5000.00 | 1243.75 | 2533.00 | 7786.75 | 0.3253 | 0.3084 |
| BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 7894.00 | 7786.75 | 1.0138 | 1.0104 | |
| BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 3.00 | 7786.75 | 0.0004 | -0.8975 | |
| BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 1.00 | 7786.75 | 0.0001 | -0.9323 | |
| BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 7833.00 | 7786.75 | 1.0059 | 1.0045 | |
| BT-20 | 17-AAG | 10 | uM | 7 | 5000.00 | 1243.75 | 2396.00 | 7786.75 | 0.3077 | 0.2812 |
| BT-20 | 17-AAG | 0.0016596 | uM | 7 | 5000.00 | 1243.75 | 7654.00 | 7786.75 | 0.9830 | 0.9871 |
| BT-20 | Lapatinib | 0.0033113 | uM | 7 | 5000.00 | 1243.75 | 7431.00 | 7786.75 | 0.9543 | 0.9650 |
| BT-20 | Erlotinib | 0.01 | uM | 7 | 5000.00 | 1243.75 | 7748.00 | 7786.75 | 0.9950 | 0.9962 |
| BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 7564.00 | 7786.75 | 0.9714 | 0.9782 | |
| BT-20 | Erlotinib | 3.1623 | uM | 7 | 5000.00 | 1243.75 | 5987.00 | 7786.75 | 0.7689 | 0.8109 |
| BT-20 | Lapatinib | 0.0016596 | uM | 7 | 5000.00 | 1243.75 | 7536.00 | 7786.75 | 0.9678 | 0.9754 |
| BT-20 | Linsitinib | 1 | uM | 7 | 5000.00 | 1243.75 | 7400.00 | 7786.75 | 0.9503 | 0.9619 |
| BT-20 | Lapatinib | 3.1623 | uM | 7 | 5000.00 | 1243.75 | 5970.00 | 7786.75 | 0.7667 | 0.8090 |
| BT-20 | Linsitinib | 0.0033113 | uM | 7 | 5000.00 | 1243.75 | 7874.00 | 7786.75 | 1.0112 | 1.0084 |
| BT-20 | 17-AAG | 0.31623 | uM | 7 | 5000.00 | 1243.75 | 2486.00 | 7786.75 | 0.3193 | 0.2991 |
| BT-20 | 17-AAG | 0.01 | uM | 7 | 5000.00 | 1243.75 | 6566.00 | 7786.75 | 0.8432 | 0.8752 |
| BT-20 | Lapatinib | 1 | uM | 7 | 5000.00 | 1243.75 | 6936.00 | 7786.75 | 0.8907 | 0.9144 |
| BT-20 | Erlotinib | 0.0033113 | uM | 7 | 5000.00 | 1243.75 | 7393.00 | 7786.75 | 0.9494 | 0.9612 |
| BT-20 | Erlotinib | 0.31623 | uM | 7 | 5000.00 | 1243.75 | 6538.00 | 7786.75 | 0.8396 | 0.8722 |